Protein S (PROS) (Middle Region) Peptide
PROS
Reactivité: Humain
Hôte: Synthetic
BP, WB, IHC
-
- Antigène Tous les produits PROS1 (PROS)
- PROS1 (PROS) (Protein S (PROS))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-PROS1 antibody (Catalog #: ARP56097_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- PROS1 (PROS) (Protein S (PROS))
- Synonymes
- PROS Peptide, PS21 Peptide, PS22 Peptide, PS23 Peptide, PS24 Peptide, PS25 Peptide, PSA Peptide, THPH5 Peptide, THPH6 Peptide, zgc:154001 Peptide, AW214361 Peptide, protein S Peptide, protein S (alpha) Peptide, PROS1 Peptide, Pros1 Peptide, pros1 Peptide
- Sujet
-
PROS1 is an anticoagulant plasma protein, it is a cofactor to activated protein C in the degradation of coagulation factors Va and VIIIa. It helps to prevent coagulation and stimulating fibrinolysis.
Alias Symbols: PROS, PS 26, PS21, PS22, PS23, PS24, PS25, PSA
Protein Interaction Partner: C4BPA,C4BPB,F10,F2,F5,F8,PROC,TYRO3,F5,F8
Protein Size: 676 - Poids moléculaire
- 71 kDa
- ID gène
- 5627
- NCBI Accession
- NM_000313, NP_000304
- UniProt
- P07225
-
Vous êtes ici:
